Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer

Xiang Wu1,2, Qingjiang Xu1,2, Pingzhou Chen1,2

  • 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, People's Republic of China.

Abstract

Insights

SMYD3 is elevated in bladder cancer cells, promoting proliferation and invasion. Suppressing SMYD3 inhibits cancer cell growth and induces apoptosis, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Bladder cancer (BLAC) is a significant health concern.
  • SMYD3 is a gene implicated in various cancers.
  • Histone methylation plays a crucial role in gene regulation and cancer development.

Purpose of the Study:

  • To investigate the role of SMYD3 in bladder cancer.
  • To analyze the effect of SMYD3 on histone 3 lysine-4 (H3K4) methylation.
  • To determine SMYD3's impact on the biological behavior of bladder cancer cells.

Main Methods:

  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to assess SMYD3 expression.
  • Short hairpin RNA (shRNA) system to suppress SMYD3 expression.
  • Western blot to analyze protein levels of SMYD3 and H3K4 methylation marks (H3K4me1, H3K4me2, H3K4me3).
  • Cell proliferation, colony formation, migration, invasion, and apoptosis assays were performed.

Main Results:

  • SMYD3 expression was significantly higher in BLAC cell lines compared to normal uroepithelial cells.
  • SMYD3 suppression using shRNA led to decreased H3K4me2 and H3K4me3 levels, but not H3K4me1.
  • Knockdown of SMYD3 resulted in increased apoptosis, reduced colony formation, proliferation, migration, and invasion.

Conclusions:

  • SMYD3 activation in bladder cancer cells enhances H3K4 methylation activity.
  • SMYD3 modulates key cancer behaviors including proliferation, migration, and invasion.
  • Targeting SMYD3 presents a potential therapeutic strategy for bladder cancer.